Abstract
Introduction: Hidradenitis suppurativa (HS) is characterized by a dysregulation of the IL-17 axis. We recently reported a clinical benefit of brodalumab, a human anti-IL-17 receptor (IL-17RA) monoclonal antibody in moderate to severe HS.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
